Coombes A G, Yeh M K, Lavelle E C, Davis S S
Department of Pharmaceutical Sciences, University of Nottingham, UK.
J Control Release. 1998 Mar 31;52(3):311-20. doi: 10.1016/s0168-3659(98)00006-6.
Poly(DL-lactide co-glycolide) microparticles below 5 microm in size and containing ovalbumin (OVA), were prepared using the water-in oil-in water (w/o/w) technique with either polyvinyl alcohol (PVA) or polyvinylpyrrolidone (PVP) as stabilisers in the external aqueous phase. PVP-stabilised microparticles exhibited higher protein loading (8.2%, w/w relative to 4.0% for PVA stabilised microparticles) and increased core loading (encapsulation) of protein (70% vs. 30% for the PVA system). The use of PVP instead of PVA to prepare microparticles also resulted in reduction in the initial burst release of OVA, together with sustained protein release over 28 days and an increase in the protein delivery capacity from 35 to 45 microg/mg particles. The changes in protein loading and delivery characteristics are considered to arise in part from an increase in the viscosity of the droplets of polymer solution, constituting the primary water-in oil emulsion, by diffusion of PVP from the external aqueous phase. Variation of the external aqueous phase surfactant provides a promising approach for improving the loading of therapeutic proteins and vaccine antigens within biodegradable microparticles and for modulating their release pattern.
采用水包油包水(w/o/w)技术,以聚乙烯醇(PVA)或聚乙烯吡咯烷酮(PVP)作为外水相中的稳定剂,制备了尺寸小于5微米且含有卵清蛋白(OVA)的聚(DL-丙交酯-共-乙交酯)微粒。PVP稳定的微粒表现出更高的蛋白质载量(8.2%,w/w,而PVA稳定的微粒为4.0%)以及蛋白质核心载量(包封率)增加(PVA体系为30%,而该体系为70%)。使用PVP而非PVA制备微粒还导致OVA的初始突释减少,蛋白质在28天内持续释放,并且蛋白质递送能力从35微克/毫克微粒提高到45微克/毫克微粒。蛋白质载量和递送特性的变化被认为部分源于PVP从外水相扩散,导致构成初级油包水乳液的聚合物溶液液滴粘度增加。外水相表面活性剂的变化为提高可生物降解微粒中治疗性蛋白质和疫苗抗原的载量以及调节其释放模式提供了一种有前景的方法。